Impact analysis of heart failure across European countries

Impact analysis of heart failure across European countries: an ESC-HFA position paper

Research output: Contribution to journal › Review › Research › peer-review

Standard

Impact analysis of heart failure across European countries : an ESC-HFA position paper. / Rosano, Giuseppe M. C.; Seferovic, Petar; Savarese, Gianluigi; Spoletini, Ilaria; Lopatin, Yuri; Gustafsson, Fin; Bayes-Genis, Antoni; Jaarsma, Tiny; Abdelhamid, Magdy; Miqueo, Arantxa Gonzalez; Piepoli, Massimo; Tocchetti, Carlo G.; Ristić, Arsen D.; Jankowska, Ewa; Moura, Brenda; Hill, Loreena; Filippatos, Gerasimos; Metra, Marco; Milicic, Davor; Thum, Thomas; Chioncel, Ovidiu; Ben Gal, Tuvia; Lund, Lars H.; Farmakis, Dimitrios; Mullens, Wilfried; Adamopoulos, Stamatis; Bohm, Michael; Norhammar, Anna; Bollmann, Andreas; Banerjee, Amitava; Maggioni, Aldo P.; Voors, Adriaan; Solal, Alain Cohen; Coats, Andrew J. S.

In: E S C Heart Failure, Vol. 9, No. 5, 2022, p. 2767-2778.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Rosano, GMC, Seferovic, P, Savarese, G, Spoletini, I, Lopatin, Y, Gustafsson, F, Bayes-Genis, A, Jaarsma, T, Abdelhamid, M, Miqueo, AG, Piepoli, M, Tocchetti, CG, Ristić, AD, Jankowska, E, Moura, B, Hill, L, Filippatos, G, Metra, M, Milicic, D, Thum, T, Chioncel, O, Ben Gal, T, Lund, LH, Farmakis, D, Mullens, W, Adamopoulos, S, Bohm, M, Norhammar, A, Bollmann, A, Banerjee, A, Maggioni, AP, Voors, A, Solal, AC & Coats, AJS 2022, 'Impact analysis of heart failure across European countries: an ESC-HFA position paper', E S C Heart Failure, vol. 9, no. 5, pp. 2767-2778. https://doi.org/10.1002/ehf2.14076

APA

Rosano, G. M. C., Seferovic, P., Savarese, G., Spoletini, I., Lopatin, Y., Gustafsson, F., Bayes-Genis, A., Jaarsma, T., Abdelhamid, M., Miqueo, A. G., Piepoli, M., Tocchetti, C. G., Ristić, A. D., Jankowska, E., Moura, B., Hill, L., Filippatos, G., Metra, M., Milicic, D., ... Coats, A. J. S. (2022). Impact analysis of heart failure across European countries: an ESC-HFA position paper. E S C Heart Failure, 9(5), 2767-2778. https://doi.org/10.1002/ehf2.14076

Vancouver

Rosano GMC, Seferovic P, Savarese G, Spoletini I, Lopatin Y, Gustafsson F et al. Impact analysis of heart failure across European countries: an ESC-HFA position paper. E S C Heart Failure. 2022;9(5):2767-2778. https://doi.org/10.1002/ehf2.14076

Author

Rosano, Giuseppe M. C. ; Seferovic, Petar ; Savarese, Gianluigi ; Spoletini, Ilaria ; Lopatin, Yuri ; Gustafsson, Fin ; Bayes-Genis, Antoni ; Jaarsma, Tiny ; Abdelhamid, Magdy ; Miqueo, Arantxa Gonzalez ; Piepoli, Massimo ; Tocchetti, Carlo G. ; Ristić, Arsen D. ; Jankowska, Ewa ; Moura, Brenda ; Hill, Loreena ; Filippatos, Gerasimos ; Metra, Marco ; Milicic, Davor ; Thum, Thomas ; Chioncel, Ovidiu ; Ben Gal, Tuvia ; Lund, Lars H. ; Farmakis, Dimitrios ; Mullens, Wilfried ; Adamopoulos, Stamatis ; Bohm, Michael ; Norhammar, Anna ; Bollmann, Andreas ; Banerjee, Amitava ; Maggioni, Aldo P. ; Voors, Adriaan ; Solal, Alain Cohen ; Coats, Andrew J. S. / Impact analysis of heart failure across European countries : an ESC-HFA position paper. In: E S C Heart Failure. 2022 ; Vol. 9, No. 5. pp. 2767-2778.

Bibtex

@article{50800490c22249d19475ab6ab741a50d,

title = "Impact analysis of heart failure across European countries: an ESC-HFA position paper",

abstract = "Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs—in terms of quality of life—in European countries.",

keywords = "Epidemiology, Heart failure, Impact, Morbidity, Mortality, Prognosis, Quality of life",

author = "Rosano, {Giuseppe M. C.} and Petar Seferovic and Gianluigi Savarese and Ilaria Spoletini and Yuri Lopatin and Fin Gustafsson and Antoni Bayes-Genis and Tiny Jaarsma and Magdy Abdelhamid and Miqueo, {Arantxa Gonzalez} and Massimo Piepoli and Tocchetti, {Carlo G.} and Risti{\'c}, {Arsen D.} and Ewa Jankowska and Brenda Moura and Loreena Hill and Gerasimos Filippatos and Marco Metra and Davor Milicic and Thomas Thum and Ovidiu Chioncel and {Ben Gal}, Tuvia and Lund, {Lars H.} and Dimitrios Farmakis and Wilfried Mullens and Stamatis Adamopoulos and Michael Bohm and Anna Norhammar and Andreas Bollmann and Amitava Banerjee and Maggioni, {Aldo P.} and Adriaan Voors and Solal, {Alain Cohen} and Coats, {Andrew J. S.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.",

year = "2022",

doi = "10.1002/ehf2.14076",

language = "English",

volume = "9",

pages = "2767--2778",

journal = "E S C Heart Failure",

issn = "2055-5822",

publisher = "JohnWiley & Sons Ltd",

number = "5",

}

RIS

TY - JOUR

T1 - Impact analysis of heart failure across European countries

T2 - an ESC-HFA position paper

AU - Rosano, Giuseppe M. C.

AU - Seferovic, Petar

AU - Savarese, Gianluigi

AU - Spoletini, Ilaria

AU - Lopatin, Yuri

AU - Gustafsson, Fin

AU - Bayes-Genis, Antoni

AU - Jaarsma, Tiny

AU - Abdelhamid, Magdy

AU - Miqueo, Arantxa Gonzalez

AU - Piepoli, Massimo

AU - Tocchetti, Carlo G.

AU - Ristić, Arsen D.

AU - Jankowska, Ewa

AU - Moura, Brenda

AU - Hill, Loreena

AU - Filippatos, Gerasimos

AU - Metra, Marco

AU - Milicic, Davor

AU - Thum, Thomas

AU - Chioncel, Ovidiu

AU - Ben Gal, Tuvia

AU - Lund, Lars H.

AU - Farmakis, Dimitrios

AU - Mullens, Wilfried

AU - Adamopoulos, Stamatis

AU - Bohm, Michael

AU - Norhammar, Anna

AU - Bollmann, Andreas

AU - Banerjee, Amitava

AU - Maggioni, Aldo P.

AU - Voors, Adriaan

AU - Solal, Alain Cohen

AU - Coats, Andrew J. S.

PY - 2022

Y1 - 2022

N2 - Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs—in terms of quality of life—in European countries.

AB - Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs—in terms of quality of life—in European countries.

KW - Epidemiology

KW - Heart failure

KW - Impact

KW - Morbidity

KW - Mortality

KW - Prognosis

KW - Quality of life

U2 - 10.1002/ehf2.14076

DO - 10.1002/ehf2.14076

M3 - Review

C2 - 35869679

AN - SCOPUS:85134550148

VL - 9

SP - 2767

EP - 2778

JO - E S C Heart Failure

JF - E S C Heart Failure

SN - 2055-5822

IS - 5

ER -

ID: 346050095

Faculty of Law